-+ 0.00%
-+ 0.00%
-+ 0.00%

LONGEVERON® ANNOUNCES LICENSING OF NEW CARDIAC SELECTIVE INDUCED PLURIPOTENT STEM CELL TECHNOLOGY FOR CARDIOVASCULAR DISEASE

Reuters·07/21/2025 13:15:00

Please log in to view news